• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

4
results for

"Uterine Cervical Neoplasms"

Filter

Article category

Keywords

Publication year

Authors

"Uterine Cervical Neoplasms"

Original Articles

Breast and Cervical Cancer Screening Behavior in Female Cancer Survivors: The Korea National Health and Nutrition Examination Survey, 2007–2012
Eun-Ae Lee, Jinyoung Shin, Eun-Joo Hwang, Jung-Woong Lee
Korean J Fam Med 2017;38(3):116-121.   Published online May 23, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.3.116
Background

The aim of this study was to compare breast and cervical cancer screening rates between female cancer survivors and a population without cancer to identify factors related to cervical and breast cancer screening in cancer survivors.

Methods

We included 17,765 adults (738 cancer survivors and 17,027 individuals without cancer) in this study, all of whom who were 30 years of age or older and participated in the Fourth and Fifth Korean National Health and Nutritional Examination Surveys from 2007–2012. Multiple logistic regression analysis was performed to identify factors related to cervical and breast cancer screening uptake in female cancer survivors.

Results

The screening rate for breast cancer was 56.6%, which was higher than that in the non-cancer control group (P=0.001). The screening rate for cervical cancer was 51.4%, which was not different from that of the non-cancer control group. In terms of breast cancer screening, cancer survivors showed no significant difference in the rate of screening 5 years after their cancer diagnosis. However, cervical cancer survivors were less likely to have cervical cancer screening 10 years after their cancer diagnosis. There was no significant association between cancer screening and sociodemographic factors.

Conclusion

Breast and cervical cancer screening rates in Korean female cancer survivors are low. Secondary primary cancer screening of female cancer survivors needs to be planned in a comprehensive manner, with the consideration of influences beyond sociodemographic factors.

Citations

Citations to this article as recorded by  
  • Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer
    Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park
    Cancer Research and Treatment.2024; 56(2): 522.     CrossRef
  • Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care
    Fernanda Mesa-Chavez, Misael Salazar-Alejo, Cynthia Villarreal-Garza
    Seminars in Oncology.2024; 51(5-6): 156.     CrossRef
  • RESEARCH ON THE IMPROVED IMAGE TRACKING ALGORITHM OF ATHLETES’ CERVICAL HEALTH
    Jingjing Jiang
    Revista Brasileira de Medicina do Esporte.2021; 27(5): 476.     CrossRef
  • Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
    Sang Yull Kang, Yoo Seok Kim, Zisun Kim, Hyun-Yul Kim, Se Kyung Lee, Kyu-Won Jung, Hyun Jo Youn
    Journal of Breast Cancer.2018; 21(1): 1.     CrossRef
  • 5,702 View
  • 48 Download
  • 6 Web of Science
  • 4 Crossref
Trends in Cervical Cancer Mortality by Socioeconomic Status in Korean Women between 1998 and 2009
Mi-Hyun Kim, Yun-Mi Song, Bo-Kyoung Kim, Sung-Min Park, Gwang Pyo Ko
Korean J Fam Med 2013;34(4):258-264.   Published online July 24, 2013
DOI: https://doi.org/10.4082/kjfm.2013.34.4.258
Background

Death from uterine cervical cancer could be preventable by an active participation of women at risk in a screening program such as the Papanicolaou test. In order to examine the presence of socioeconomic disparity in preventable deaths, we evaluated the time trends of cervical cancer mortality by socioeconomic status in Korean women.

Methods

We selected level of educational attainment and marital status as surrogate indices of socioeconomic status. Using death certificate data and Korean Population and Housing Census data from Korea National Statistical office, we calculated age-standardized yearly mortality rates from cervical cancer between 1998 and 2009 according to the level of education as well as marital status.

Results

Cervical cancer mortality peaked in 2003 and then decreased gradually over time. Cervical cancer mortality was the highest in the group with the lowest level of educational attainment in all age groups and the gap between the lowest and the highest educational level has increased over time. Cervical cancer mortality was lower in married women than unmarried women in all age groups, and the degree of difference did not change over time.

Conclusion

In the Korean population, socioeconomic differential in cervical cancer mortality has persisted over time.

Citations

Citations to this article as recorded by  
  • The participation in cervical cancer screening is not altered by the Hawthorne effect among patients of doctors participating in the randomized clinical trial PaCUDAHL
    Gabrielle Lisembard, Michaël Rochoy, François Quersin, Valérie Deken, Alain Duhamel, Axel Descamps, Christophe Berkhout, Fanny Serman
    BMC Research Notes.2025;[Epub]     CrossRef
  • Income-based disparities in the risk of distant-stage cervical cancer and 5-year mortality after the introduction of a National Cancer Screening Program in Korea
    Erdenetuya Bolormaa, Seung-Ah Choe, Mia Son, Myung Ki, Domyung Paek
    Epidemiology and Health.2022; 44: e2022066.     CrossRef
  • The association between cervical cancer screening participation and the deprivation index of the location of the family doctor’s office
    Fanny Serman, Jonathan Favre, Valérie Deken, Lydia Guittet, Claire Collins, Michaël Rochoy, Nassir Messaadi, Alain Duhamel, Ludivine Launay, Christophe Berkhout, Thibaut Raginel, Tayyab Ikram Shah
    PLOS ONE.2020; 15(5): e0232814.     CrossRef
  • Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer
    Minh-Phuong Huynh-Le, Amy Klapheke, Rosemary Cress, Loren K. Mell, Catheryn M. Yashar, John P. Einck, Arno J. Mundt, Jyoti S. Mayadev
    Brachytherapy.2019; 18(5): 612.     CrossRef
  • Association between Socioeconomic Status and Cancer Screening in Koreans over 40 Years in Age Based on the 2010–2012 Korean National Health and Nutrition Examination Survey
    Jin-Young Kim, Hee-Taik Kang
    Korean Journal of Family Medicine.2016; 37(5): 287.     CrossRef
  • Cervical cancer still presents symptomatically 20 years after the introduction of a structured national screening programme
    E. Myriokefalitaki, N. Potdar, L. Barnfield, Q. Davies, E. L. Moss
    Cytopathology.2016; 27(4): 229.     CrossRef
  • Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output
    Maricruz Anaya-Ruiz, Ana Karen Vincent, Martin Perez-Santos
    Asian Pacific Journal of Cancer Prevention.2014; 15(20): 8689.     CrossRef
  • 5,367 View
  • 21 Download
  • 7 Crossref
Factors Associated with the Use of Uterine Cervical Cancer Screening Services in Korean Elderly Women
Ki Dong Ko, Sang Min Park, Kiheon Lee
Korean J Fam Med 2012;33(3):174-181.   Published online May 24, 2012
DOI: https://doi.org/10.4082/kjfm.2012.33.3.174
Background

The Papanicolaou (Pap) smear test is an effective screening test for the early detection of uterine cervical cancer. The Pap test still plays an important role in Korean elderly women, as uterine cervical cancer remains a frequent form of cancer and an important cause of death. However, the participation rate and other factors related to the Pap test in Korean elderly women have been studied insufficiently.

Methods

This study included 654 individuals aged 65 and over who completed a cervical cancer screening questionnaire from the Third Korean National Health and Nutrition Examination Survey 2005. Using multiple logistic regression, odds ratios and confidence intervals for the association between attendance of the Pap test and sociodemographic or health-related factors were calculated.

Results

One hundred and eleven individuals (17.0%) of the study population showed compliance with Pap testing within the previous 2 years. We recognized that the most elderly women (75 years and over) or those with lower levels of education were less likely to have had the test.

Conclusion

Primary health care providers need to make efforts to improve attendance rates of Pap smear screening in Korean elderly women, individually taking into account previous Pap results, life expectancy, risk factors for cervical cancer, and preferences. More attention will especially be needed among the eldest elderly or less educated elderly women.

Citations

Citations to this article as recorded by  
  • Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years
    Jong-Yeup Kim, Jeeyoung Hong, Juhee Yoon, Jinsol Park, Tae-Hyun Kim
    Journal of Gynecologic Oncology.2024;[Epub]     CrossRef
  • Cervical Cancer Screening and Its Associated Factors Among North Korean Defectors Living in South Korea
    Jeongok Park, HeesSook Kim, Wonhee Yang, HaeWon Lee, Sang Min Park
    Journal of Immigrant and Minority Health.2018; 20(1): 66.     CrossRef
  • Disparities in the utilisation of preventive health services by the employment status: An analysis of 2007-2012 South Korean national survey
    SangJune Kim, Jee Hey Song, Yoo Min Oh, Sang Min Park, Geofrey Musinguzi
    PLOS ONE.2018; 13(12): e0207737.     CrossRef
  • Role of cervical screening in older women
    Laurie Elit
    Maturitas.2014; 79(4): 413.     CrossRef
  • 5,244 View
  • 19 Download
  • 4 Crossref
Controlled Clinical Trial
Cervical Cancer and Human Papillomavirus Vaccines.
Sunyoung Kim, Jung Im Kwak, Yun Mi Song
J Korean Acad Fam Med 2008;29(11):821-830.   Published online November 10, 2008
The necessary role of genital infection by specific types of human papillomavirus (HPV) in cervical cancer development provides an opportunity to reduce the risk of cervical cancer, a second leading cancer in women, through prophylactic vaccination. Two types of vaccines targeting HPV 16 and 18 which are responsible for about 70% of all cervical cancer worldwide have been developed: a quadrivalent vaccine (Gardasil) and a bivalent vaccine (Cervarix). Gardasil also targets HPV 6 and 11 causing 90% of genital wart. Both two vaccines contain virus-like particles composed of L1 protein of viral capsid and do not exert infectivity. HPV vaccines were highly effective in preventing persistent infection by vaccine specific type HPV in young women who have not been previously exposed to them. Randomized double- blind placebo-controlled clinical trials have provided evidence that HPV vaccines have high efficacy against cervical precancerous lesion in young women irrespective of baseline HPV infection status. However, HPV vaccines neither treat existing HPV infections nor provide protection against all types of HPV related with cervical cancer. Therefore, even vaccinated females should take cervical cancer screening as recommended. Gardasil has been tested mainly in 9∼26 years old females and Cervarix in 15∼25 years old. Current recommendation for vaccination age is 9∼26 years for Gardasil and 10∼25 years for Cervarix, considering sexual debut and previous clinical trials. There are plenty of remaining issues regarding HPV vaccination such as vaccine efficacy in older women and in males, cost-effectiveness, duration of protection, cross-protection, potential replacement infection, and vaccine compatibility. (J Korean Acad Fam Med 2008;29:821-830)
  • 1,733 View
  • 18 Download
TOP